Literature DB >> 11410860

Second primary neoplasms in 633,964 cancer patients in Sweden, 1958-1996.

C Dong1, K Hemminki.   

Abstract

The Swedish Family-Cancer Database was used to analyze concordant (same site) and discordant (different site) second primary neoplasms in 633,964 cancer patients diagnosed from 1958 to 1996. Cases of second malignant neoplasms were extracted from the Database if the diagnosis date of the first and second cancer differed by at least 1 month. The expected numbers of cancers were obtained by applying site-, sex-, age-, period-, residence- and socioeconomic level-specific rates in the corresponding population in the Database to the appropriate person-years at risk. The standardized incidence ratio (SIRs) of a second cancer was taken to be the ratio of observed to expected numbers of second cancers. Of all cancers, 8.5% were subsequent neoplasms (8.4% for males and 8.7% for females). SIRs for both concordant and discordant subsequent cancer were elevated in patients with cancer of the upper aerodigestive tract, colon, nose, breast, other female genitals, testis, kidney, urinary, bladder, skin, nervous system, endocrine, bone, connective tissue, melanoma, lymphoma and leukemia. The risks at some concordant sites, such as nose, squamous cell skin, bone and connective tissue in both sexes, breast in males and upper aerodigestive tract and leukemia in females, were very high (>10). At discordant sites, SIRs were less than 2 but significantly increased after all but gastric and prostatic cancer. Compared with the general population, cancer patients were at a modestly increased risk for new primary cancer after cancers at many sites, calling for attention in treatment, management and prevention. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11410860     DOI: 10.1002/ijc.1317

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  43 in total

1.  Serum antioxidant capacity, biochemical profile and body composition of breast cancer survivors in a randomized Mediterranean dietary intervention study.

Authors:  Maria Skouroliakou; D Grosomanidis; P Massara; C Kostara; P Papandreou; D Ntountaniotis; G Xepapadakis
Journal:  Eur J Nutr       Date:  2017-06-20       Impact factor: 5.614

2.  Incidence of multiple primary malignancies among patients with bone cancers in Sweden.

Authors:  Jianguang Ji; Kari Hemminki
Journal:  J Cancer Res Clin Oncol       Date:  2006-05-17       Impact factor: 4.553

3.  Incidence of metachronous second primary cancers in Osaka, Japan: update of analyses using population-based cancer registry data.

Authors:  Takahiro Tabuchi; Yuri Ito; Akiko Ioka; Isao Miyashiro; Hideaki Tsukuma
Journal:  Cancer Sci       Date:  2012-04-11       Impact factor: 6.716

4.  Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry.

Authors:  Michael D Walsh; Daniel D Buchanan; Margaret C Cummings; Sally-Ann Pearson; Sven T Arnold; Mark Clendenning; Rhiannon Walters; Diane M McKeone; Amanda B Spurdle; John L Hopper; Mark A Jenkins; Kerry D Phillips; Graeme K Suthers; Jill George; Jack Goldblatt; Amanda Muir; Kathy Tucker; Elise Pelzer; Michael R Gattas; Sonja Woodall; Susan Parry; Finlay A Macrae; Robert W Haile; John A Baron; John D Potter; Loic Le Marchand; Bharati Bapat; Stephen N Thibodeau; Noralane M Lindor; Michael A McGuckin; Joanne P Young
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

5.  Unexpected Second Primary Malignancies Detected by F-18 FDG PET/CT During Follow-up for Primary Malignancy: Two Case Reports.

Authors:  Ji-In Bang; Eun Seong Lee; Tae-Sung Kim; Seok-Ki Kim
Journal:  Nucl Med Mol Imaging       Date:  2014-10-30

6.  Urothelial cancer and the diagnosis of subsequent malignancies.

Authors:  Deepak K Pruthi; Zoann Nugent; Piotr Czaykowski; Alain A Demers
Journal:  Can Urol Assoc J       Date:  2013 Jan-Feb       Impact factor: 1.862

7.  What is the most cost-effective strategy to screen for second primary colorectal cancers in male cancer survivors in Korea?

Authors:  Sang-Min Park; Sun-Young Kim; Craig-C Earle; Seung-Yong Jeong; Young-Ho Yun
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

8.  The clinical significance of 18F-FDG-PET/CT in early detection of second primary malignancy in cancer patients.

Authors:  Haoping Xu; Miao Zhang; Ge Zhai; Biao Li
Journal:  J Cancer Res Clin Oncol       Date:  2010-01-22       Impact factor: 4.553

9.  Increased cumulative incidence of prostate malignancies in colorectal cancer patients.

Authors:  Nuri Ozden; Murat Saruc; Lynette M Smith; Arthi Sanjeevi; Hemant K Roy
Journal:  Int J Gastrointest Cancer       Date:  2003

10.  Prostate cancer as a first and second cancer: effect of family history.

Authors:  H Zhang; J L Bermejo; J Sundquist; K Hemminki
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.